Lunawel centers on a scientifically validated functional chocolate engineered specifically as a therapeutic delivery system for the management of primary dysmenorrhea. The core product innovation is driven by our proprietary lipid-nanoparticle encapsulation technology. Unlike traditional, unpalatable botanical remedies that suffer from poor adherence or standard synthetic NSAIDs that cause cumulative gastrointestinal toxicity in young women, our deep-tech formulation structurally shields volatile therapeutic phytochemicals and highly bioavailable minerals within a premium cocoa matrix. Specifically, our formulation utilizes Magnesium Bisglycinate(chosen over standard Magnesium Glycerophosphate for its superior gastrointestinal tolerance and optimal cellular absorption) paired with natural Sweet Fennel Oil to effectively target uterine inflammation and muscle spasms. Our advanced encapsulation process completely masks the inherent bitter tastes of these active botanicals, prevents thermal and UV degradation during shelf storage and guarantees an exceptionally high oral absorption profile. Currently operating at TRL-6, our innovation bridges the critical gap between clinical efficacy and pediatric compliance. We have successfully secured official clearance from the Institutional Human Ethics Committee to conduct a rigorous 250-subject clinical trial to provide empirical validation of our formulation. By integrating advanced biotechnology into a highly palatable, everyday consumer food format, Lunawel is directly addressing a massive unmet need in adolescent women's healthcare, aiming to drastically reduce severe school absenteeism caused by menstrual pain. Furthermore, our model relies entirely on indigenous R&D and manufacturing, aligning strictly with 'Make in India' mandates as we prepare for FSSAI-compliant commercialization and a targeted quick-commerce market rollout.
Show MoreYear of Establishment2026